Amber Therapeutics

Developer of a bioelectronic platform designed to generate novel, neuromodulation therapies. The company focuses on the peripheral instead of the central nervous system to develop novel bioelectrical ...

Healthcare
London, United Kingdom
Founded 2020
45 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$101.4M
Last Round
N/A

Get the full picture

Create a free account to unlock Amber Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required